Hypermetabolism in ALS Using Six REE Formulas
NCT03382392 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 449
Last updated 2017-12-22
Summary
Introduction: About 50-60% of Amyotrophic Lateral Sclerosis (ALS) is characterized by hypermetabolism, defined as 10% or more excess resting energy expenditure (REE) compared to theoretical values. Harris and Benedict's (HB) formula is the equation mainly used to predict REE, but others are also applied in current practice. The present study aimed to assess REE in ALS patients compared to control populations and to compare six formulas commonly used to predict REE.
Nutritional assessments were performed in ALS patients and in two control populations without hypermetabolism: healthy elderly people (control 1) and patients with non-restrictive-eating disorders (control 2). Weight, height and body composition (by bioimpedance analysis) were assessed.
EE was measured (mREE) by indirect calorimetry and calculated (cREE) using HB 1919 and 1984, World Schofield, De Lorenzo, Johnstone and Mifflin formulas. Mann-Whitney and Chi2 tests were used to compare the equations.
Conditions
Interventions
- OTHER
-
Assesment of REE in ALS patients compared to control populations and to compare six formulas commonly used to predict REE.
Sponsors & Collaborators
-
University Hospital, Limoges
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1996-11-30
- Primary Completion
- 2014-11-30
- Completion
- 2014-11-30
Countries
- France
Study Locations
More Related Trials
-
Safety and Tolerability Ultra-high-caloric Food Supplements in Amyotrophic Lateral Sclerosis (ALS)
NCT04172792 ·Status: COMPLETED ·Phase: PHASE1
-
New Therapeutic Strategy in ALS Based on Metabolic Status and Associated Metabolic Pathways.
NCT03984708 ·Status: COMPLETED ·Phase: NA
-
Exercise and Disease Progression in Amyotrophic Lateral Sclerosis Patients
NCT03326622 ·Status: COMPLETED ·Phase: NA
-
Quantitative Measurement of Nutritional Substrate Utilization in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT00714220 ·Status: TERMINATED
-
In-situ Cytokines Expression in the CNS in Amyotrophic Lateral Sclerosis (ALS)
NCT02582385 ·Status: COMPLETED
-
Spinal Interneuron Excitability in ALS
NCT02429492 ·Status: COMPLETED ·Phase: NA
-
Effects of Gastrostomy on Amyotrophic Lateral Sclerosis
NCT00337402 ·Status: COMPLETED
-
Nocturnal PtcCO2 Monitoring in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT00879593 ·Status: COMPLETED ·Phase: NA
-
Hyperlipidemia and Statin Therapy in Amyotrophic Lateral Sclerosis
NCT01592084 ·Status: COMPLETED
-
Oral Nutritional Supplementation in Amyotrophic Lateral Sclerosis (ALS) Patients
NCT02152449 ·Status: COMPLETED ·Phase: NA
-
High Fat/High Calorie Trial in Amyotrophic Lateral Sclerosis
NCT00983983 ·Status: COMPLETED ·Phase: PHASE2
-
French-German Cohort Study to Determine Factors Associated With Weight Loss in Amyotrophic Lateral Sclerosis
NCT06147843 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Metabolomic Analysis in Early Diagnosis of ALS
NCT01962311 ·Status: COMPLETED ·Phase: NA
-
Determining the Safety of L-serine in ALS
NCT01835782 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Neuroinflammation in Amyotrophic Lateral Sclerosis - Mechanisms and Therapeutic Perspectives: a Translational Pilot Study Among ALS Patients
NCT02424669 ·Status: UNKNOWN ·Phase: NA
-
Measurement and Impact of Physical Impairment in Amyotrophic Lateral Sclerosis: Use of Digital Technologies - A Precision ALS Project
NCT06820008 ·Status: RECRUITING
-
Influence of the Vitamin D Blood Levels on the Amyotrophic Lateral Sclerosis Phenotype
NCT01823380 ·Status: COMPLETED ·Phase: NA
-
Natural History and Clinical Features of Amyotrophic Lateral Sclerosis (ALS)
NCT04454892 ·Status: RECRUITING
-
Neurofilament Light Chain in Amyotrophic Lateral Sclerosis
NCT06201650 ·Status: RECRUITING
-
Study of miRNA Expression Pattern as Diagnostic and Prognostic Biomarker in Amyotrophic Lateral Sclerosis
NCT01992029 ·Status: TERMINATED
-
Dynamic Impact of NIV on Diaphragmatic Ultrasound in Patients With Amyotrophic Lateral Sclerosis
NCT07170865 ·Status: NOT_YET_RECRUITING
-
Noninvasive Assessment of Neuronal Damage by MRI Sodium ( 23Na ) in Amyotrophic Lateral Sclerosis
NCT02874209 ·Status: UNKNOWN ·Phase: NA
-
Feasibility of Telesurveillance and Home Cough Assistance for Amyotrophic Lateral Patients (ALS)
NCT00613899 ·Status: COMPLETED ·Phase: PHASE4
-
Methodology Study of Novel Outcome Measures to Assess Progression of ALS
NCT02611674 ·Status: COMPLETED
-
Influence of Olfacto-gustatory Sensoriality on the Nutritional Status of Patients With Amyotrophic Lateral Sclerosis
NCT06608004 ·Status: RECRUITING